Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P0
Near historical low
vs 2Y Ago
-2.7x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-63.73M-51.7%
2024$-42.00M-278.2%
2023$23.57M+200.2%
2022$-23.54M+16.9%
2021$-28.34M-